Clinical Trial Update: Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of low-dose interleukin-2 in patients with systemic lupus erythematosus and cytomegalovirus viremia; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Systemic Lupus Erythematosus

Drugs mentioned

• Low-dose Interleukin-2 (interleukin-2)

Snippet

Sponsor: Peking University People's Hospital | Conditions: SLE (Systemic Lupus), CMV | Phase 2 | Status: NOT_YET_RECRUITING